(Q45972746)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19519964%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

The effect of bosentan in patients with a failing Fontan circulation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19519964%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19519964%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Philip Moons

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19519964%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Luc Mertens

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19519964%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Caroline Ovaert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19519964%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Daisy Thijs

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19519964%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Jaap Ottenkamp

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19519964%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Hugues Dessy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19519964%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Marc Gewillig

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19519964%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

11 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19519964%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

published in

Cardiology in the Young

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19519964%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19519964%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19519964%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

331-339

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19519964%20AND%20SRC:MED&resulttype=core&format=json

Resolution of protein-losing enteropathy and normalization of mesenteric Doppler flow with sildenafil after Fontan

31 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

Endothelin receptor antagonists: current status and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

The endothelin antagonist BQ123 reduces pulmonary vascular resistance after surgical intervention for congenital heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

Long-term results of the Fontan operation for double-inlet left ventricle

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

Basal pulmonary vascular resistance and nitric oxide responsiveness late after Fontan-type operation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

Functional outcome after the Fontan operation: factors influencing late morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

Fontan operation in five hundred consecutive patients: factors influencing early and late outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

21 January 2018

The Fontan circulation.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

Combined therapy with inhaled nitric oxide and intravenous epoprostenol (prostacyclin) for critical pulmonary perfusion after the Fontan procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

Bosentan induces clinical, exercise and hemodynamic improvement in a pre-transplant patient with plastic bronchitis after Fontan operation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

Effects of long-term bosentan in children with pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

Pulmonary vasodilation therapy with sildenafil citrate in a patient with plastic bronchitis after the Fontan procedure for hypoplastic left heart syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

7 January 2021

Evidence of pulmonary vascular disease after heart transplantation for Fontan circulation failure

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

7 January 2021

Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

7 January 2021

The modified fontan procedure: early and late results in 132 adult patients

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

7 January 2021

Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

7 January 2021

Bosentan therapy for pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

7 January 2021

Improved early morbidity and mortality after Fontan operation: the Mayo Clinic experience, 1987 to 1992

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

7 January 2021

The 6-minute walk test: normal values for children of 4-11 years of age

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

7 January 2021

Sitaxsentan treatment for patients with pulmonary arterial hypertension discontinuing bosentan

1 reference

https://api.crossref.org/works/10.1017%2FS1047951109990023

7 January 2021

10.1017/S1047951109990023

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19519964%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference